Takeda Pharmaceutical Company Limited
Prevention and reduction of blood loss
Last updated:
Abstract:
Methods are described for preventing or reducing ischemia and/or systemic inflammatory response in a patient such as perioperative blood loss and/or systemic inflammatory response in a patient subjected to cardiothoracic surgery, e.g. coronary artery bypass grafting and other surgical procedures, especially when such procedures involve extra-corporeal circulation, such as cardiopulmonary bypass.
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
31 May 2022